Advances in Minimally Invasive Treatments for Prostate Cancer: A review of the Role of Ultrasound Therapy and Laser therapy

Abstract

Prostate cancer (PCa) remains a leading malignancy among men globally. While conventional treatments like radical prostatectomy and radiation therapy are effective, they are often associated with significant adverse effects, including sexual dysfunction and urinary incontinence. This has driven the development of minimally invasive therapies, such as ultrasound-based and laser-based treatments, which offer reduced side effects and faster recovery. This review aims to synthesize recent advancements in ultrasound and laser therapies for Pca, specifically examining their therapeutic roles in both localized and advanced disease settings. A comprehensive search was conducted on PubMed (pubmed.ncbi.nlm.nih.gov) for publications from the past decade (2015-2024) using the search criteria: ((((ultrasound[Title]) OR (laser therapy[Title])) AND (Prostate cancer[Title]))). The search was refined to include randomized controlled trials, clinical trials, meta-analyses, and reviews comparing these treatments, while excluding non-treatment investigations and basic science studies not directly related to therapeutic application. Findings from 29 peer-reviewed articles were extracted, focusing on treatment efficacy, safety profiles, and comparative analyses against conventional methods. In addition to the 29 studies identified through the systematic PubMed search, supplementary references were incorporated to provide essential contextual background, support methodological frameworks, and enrich the discussion of emerging technologies and clinical implications. These additional sources were identified through manual screening of bibliographies from key review articles, expert recommendations, and targeted searches for recent publications in peer-reviewed, indexed medical journals. Although these references were not part of the original search strategy focused strictly on therapeutic outcomes, their inclusion was essential to ensure a comprehensive and balanced synthesis of the current landscape. The analyzed studies demonstrate substantial progress in the application of ultrasound and laser therapies for PCa. HIFU consistently achieved precise tumor ablation with minimal collateral damage, leading to superior urinary and sexual function outcomes compared to traditional approaches. Similarly, laser therapy exhibited accurate tumor targeting and favorable safety profiles due to reduced thermal spread. Across 28 studies, overall survival and biochemical recurrence rates for early-stage PCa were found to be comparable to or better than those of conventional treatments. Patient-reported outcomes indicated higher satisfaction, attributed to shorter recovery periods and fewer long-term complications. However, challenges such as incomplete tumor ablation and variable efficacy based on tumor characteristics were noted. The current body of evidence also highlights a need for more long-term follow-up data to ascertain the durability of these modalities. Minimally invasive therapies, particularly HIFU and laser therapy, represent a transformative shift in Pca management. These modalities provide precise, non-invasive alternatives to traditional treatments, offering reduced side effects. While promising for both primary and salvage settings, ongoing research and technological refinements are crucial to optimize their efficacy and expand their clinical utility. The continued evolution of MRI-guided and combination therapies suggests that these minimally invasive approaches are poised to become foundational in Pca treatment, ultimately improving patient outcomes and quality of life.

Topics & Concepts